期刊文献+

青春期功能失调性子宫出血诊治进展 被引量:10

Progress in the diagnosis and treatment of hebetic dysfunctional uterine bleeding
下载PDF
导出
摘要 青春期功能失调性子宫出血(hebetic dysfunctional uterine bleeding,以下简称青春期功血)多为无排卵性功血,是指初潮后1年~2年内由于下丘脑-垂体-卵巢轴(hypothalamic-pituitary-ovarian axis,HPO)发育不完善,引起生殖内分泌系统紊乱而造成的子宫长期无规律性出血,为青春期女性(10岁~19岁)常见疾病。治疗方法包括药物和手术,目前临床多以复方口服避孕药、雌孕激素序贯疗法、雌激素、孕激素等激素类药物治疗为主。本文对近年来青春期功血的相关诊治进展加以综述。 Hebetic dysfunctional uterine bleeding is a non-ovulatory dysfunctional uterine bleeding. It refers to the long-term irregular bleeding of uterus caused by the disorder of the reproductive endocrine system within 1 to 2 years after menarche due to the imperfect development of the hypothalamic-pituitary-ovarian axis. It is a common disease among adolescent girls from 10 to 19 years old. Therapeutic methods to this disease include drugs and surgery. At present, the clinical treatments are mainly hormone drugs, such as combined oral contraceptives, sequential therapy with estrogen and progesterone, estrogen and progesterone. This article will review the progress in the diagnosis and treatment of hebetic dysfunctional uterine bleeding in recent years.
作者 包媛媛 洛若愚 BAO Yuanyuan;LUO Ruoyu(Wuhan University,Wuhan 430060,Hubei,China;Department of Gynecology,Renmin Hospital of Wuhan University,Wuhan 430060,Hubei,China)
出处 《中国性科学》 2019年第9期61-64,共4页 Chinese Journal of Human Sexuality
关键词 青春期功能失调性子宫出血 临床治疗 研究进展 Hebetic dysfunctional uterine bleeding Clinical treatment Research progress
  • 相关文献

参考文献6

二级参考文献62

  • 1王秀霞,方媛媛.青春期功能失调性子宫出血的诊治特点[J].中国实用妇科与产科杂志,2006,22(9):660-662. 被引量:34
  • 2葛秦生 见:葛秦生 连利娟主编.功能失调性子宫出血[A].见:葛秦生,连利娟主编.生殖内分泌与妇产科疾病诊治手册[C].北京:中国协和医科大学出版社,2002.409-410.
  • 3Astrup K,Olivarius NF.Frequency of spontaneously occurring postmenopausal bleeding in the general population[J].Acta Obstet Gynecol Seand,2004,83:203-207.
  • 4Bongens MY,Mol BW,Lmann HA.Current treatment of dysfunctional uterine bleeding[J].Maturitas,2004,47 (3):159-174.
  • 5Scully RE,Young RH,Crum CP.Postgraduate course in Gynecologic and Obstestric pathology with clinical correlation[J].American journal of surgical pathology,1995,19 (12):1450.
  • 6Munro MG.Medical management of abnormal uterine bleeding[J].Obstet Gynecol Clin North Am,2000,27(2):287-304.
  • 7Vereide AB,Kaino T,Sager G,et al.Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors(PRA and PRB),and estrogen receptors(Eralpha and ER-beta)in human endometrial hyperplasia[J].Gynecol Oncol,2006,101(2):214-223.
  • 8Buttini MJ,Jordan SJ,Webb PM.The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia:an Australian study and systematic review[J].Aust N Z J Obstet Gynaecol,2009,49(3):316-322.
  • 9Varma R,Soneja H,Bhatia K,et al.The effectiveness of a levonorgestrel-releasing intrauterine system(LNG-IUS)in the treatment of endometrial hyperplasia--a long-term follow-up study[J].Eur J Obstet Gynecol Reprod Biol,2008,139 (2):169-175.
  • 10Kingman CE,Kadir RA,Lee CA,et al.The use of levonorgestrel releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders[J].Br J Obstet Gynaecol,2004,111(12):1425-1428.

共引文献63

同被引文献91

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部